BillsHH.R. 9635
To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.
Stage
In committee
Latest action
Referred to the House Committee on Energy and Commerce.
July 9, 2026
Committees
- PrimaryEnergy and Commerce Committee
Action history
- July 9, 2026Introduced in House
- July 9, 2026Introduced in House
- July 9, 2026Referred to the House Committee on Energy and Commerce.